A schizophrenia medication previously required daily has now been developed as a once-monthly subcutaneous (SC) injection. On October 9, the U.S. Food and Drug Administration (FDA) approved Israeli ...

Antipsychotic injections upon hospital discharge were associated with a 75% reduction in 30-day rehospitalizations when compared with oral antipsychotics, according to a Rutgers Health study. The ...